Declerck P - Search Results

1

Immunogenicity of immunomodulatory, antibody-based, oncology therapeutics.

Davda J, Declerck P, Hu-Lieskovan S, Hickling TP, Jacobs IA, Chou J, Salek-Ardakani S, Kraynov E. Davda J, et al. Among authors: declerck p. J Immunother Cancer. 2019 Apr 15;7(1):105. doi: 10.1186/s40425-019-0586-0. J Immunother Cancer. 2019. PMID: 30992085 Free PMC article. Review.

2

The Language of Biosimilars: Clarification, Definitions, and Regulatory Aspects.

Declerck P, Danesi R, Petersel D, Jacobs I. Declerck P, et al. Drugs. 2017 Apr;77(6):671-677. doi: 10.1007/s40265-017-0717-1. Drugs. 2017. PMID: 28258517 Free PMC article. Review.

3

Monoclonal Antibody Biosimilars in Oncology: Critical Appraisal of Available Data on Switching.

Declerck P, Bakalos G, Zintzaras E, Barton B, Schreitmüller T. Declerck P, et al. Clin Ther. 2018 May;40(5):798-809.e2. doi: 10.1016/j.clinthera.2018.03.018. Epub 2018 Apr 24. Clin Ther. 2018. PMID: 29699853 Free article.

4

The arrival of biosimilar monoclonal antibodies in oncology: clinical studies for trastuzumab biosimilars.

Barbier L, Declerck P, Simoens S, Neven P, Vulto AG, Huys I. Barbier L, et al. Among authors: declerck p. Br J Cancer. 2019 Jul;121(3):199-210. doi: 10.1038/s41416-019-0480-z. Epub 2019 Jul 1. Br J Cancer. 2019. PMID: 31257362 Free PMC article. Review.

5

DNA-Based Delivery of Checkpoint Inhibitors in Muscle and Tumor Enables Long-Term Responses with Distinct Exposure.

Jacobs L, De Smidt E, Geukens N, Declerck P, Hollevoet K. Jacobs L, et al. Among authors: declerck p. Mol Ther. 2020 Apr 8;28(4):1068-1077. doi: 10.1016/j.ymthe.2020.02.007. Epub 2020 Feb 13. Mol Ther. 2020. PMID: 32101701 Free PMC article.

6

Intratumoral DNA-based delivery of checkpoint-inhibiting antibodies and interleukin 12 triggers T cell infiltration and anti-tumor response.

Jacobs L, Yshii L, Junius S, Geukens N, Liston A, Hollevoet K, Declerck P. Jacobs L, et al. Among authors: declerck p. Cancer Gene Ther. 2022 Jul;29(7):984-992. doi: 10.1038/s41417-021-00403-8. Epub 2021 Nov 9. Cancer Gene Ther. 2022. PMID: 34754076

7

Bridging the Clinical Gap for DNA-Based Antibody Therapy Through Translational Studies in Sheep.

Hollevoet K, De Vleeschauwer S, De Smidt E, Vermeire G, Geukens N, Declerck P. Hollevoet K, et al. Among authors: declerck p. Hum Gene Ther. 2019 Nov;30(11):1431-1443. doi: 10.1089/hum.2019.128. Epub 2019 Sep 10. Hum Gene Ther. 2019. PMID: 31382777

8

Miniaturized single-cell technologies for monoclonal antibody discovery.

Van Lent J, Breukers J, Ven K, Ampofo L, Horta S, Pollet F, Imbrechts M, Geukens N, Vanhoorelbeke K, Declerck P, Lammertyn J. Van Lent J, et al. Among authors: declerck p. Lab Chip. 2021 Sep 28;21(19):3627-3654. doi: 10.1039/d1lc00243k. Lab Chip. 2021. PMID: 34505611 Review.

9

Clinically relevant dosing and pharmacokinetics of DNA-encoded antibody therapeutics in a sheep model.

Hollevoet K, Thomas D, Compernolle G, Vermeire G, De Smidt E, De Vleeschauwer S, Smith TRF, Fisher PD, Dewilde M, Geukens N, Declerck P. Hollevoet K, et al. Among authors: declerck p. Front Oncol. 2022 Oct 3;12:1017612. doi: 10.3389/fonc.2022.1017612. eCollection 2022. Front Oncol. 2022. PMID: 36263202 Free PMC article.

10

The Efficacy, Safety, and Immunogenicity of Switching Between Reference Biopharmaceuticals and Biosimilars: A Systematic Review.

Barbier L, Ebbers HC, Declerck P, Simoens S, Vulto AG, Huys I. Barbier L, et al. Among authors: declerck p. Clin Pharmacol Ther. 2020 Oct;108(4):734-755. doi: 10.1002/cpt.1836. Epub 2020 Apr 30. Clin Pharmacol Ther. 2020. PMID: 32236956 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

310 results

Search Page